President Donald Trump’s impeachment trial with Senate kicks in on Tuesday this week and GOP senators remain divided about calling impeachment witnesses.
At least a handful of impeachment managers want Senate to allow new witnesses, but GOP members might be against it. Those who aren’t against it in general have different ideas.
They want to suggest postponing the witnesses until members of the House have made their case, then proceed with witnesses after the fact, as reported on Politico.
Several of the House managers for the impeachment trial, including Reps. Adam Schiff of California, Jerry Nadler and Hakeem Jeffries of New York, and Jason Crow of Colorado, appeared on Sunday news shows to urge the Senate to allow new witnesses and evidence during the process as they seek to oust Trump from office. These Democrats repeatedly pushed the line that the only way to get a “fair trial” is through additional testimony and documents.
Senate Majority Leader Mitch McConnell (R-Ky.) and other Republicans intend to offer an organizing resolution for the trial that postpones the question of calling witnesses until the House has presented its case and the president’s legal team responds. Then, following a period in which senators are allowed to ask questions of both sides, the Senate will hold a vote on whether to call more witnesses. If no witnesses are called, the trial can move to its final stages, possibly by the time Trump gives his State of the Union address on Feb. 4.
With that said, we may not know until the start of trial on Tuesday to see what happens.
CBS News covered this in a bit more detail, with focus on the GOP senators and their divide.
They shared the following video with the caption:
With the Senate impeachment trial of President Trump set to begin in the coming days, Republicans remain divided on the subject of calling for witnesses. Majority Leader Mitch McConnell is expected to introduce a resolution outlining the details of the trial process on Tuesday. USA Today’s D.C. bureau chief Susan Page joins CBSN’s Omar Villafranco with a look at the latest developments